195. ヌーナン症候群 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 38 / 薬物数 : 27 - (DrugBank : 7) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 96
薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
Blood and urine sampling
University Hospital, Toulouse
2022 - NCT05202210 France
Blood sample
Assistance Publique - Hôpitaux de Paris
2024 - NCT06147414 France
Growth hormone
Fujioka Koichi
2022 Phase 3 JPRN-jRCT2031220263 Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russia;Saudi Arabia;Serbia;Slovenia;South Africa;South Korea;Spain;Switzerland
Human growth hormone
BioMarin Pharmaceutical
2024 Phase 2 NCT06668805 France;Spain;United States
Shallghai Children's Medical Center
2022 Phase 4 ChiCTR2200065823 China
Lamotrigin beta
Technische Universität München, Fakultät für Medizin
2018 Phase 2 EUCTR2016-005022-10-DE Germany
Lovastatin
Technische Universität München, Fakultät für Medizin
2018 Phase 2 EUCTR2016-005022-10-DE Germany
Maxomat ®, biosynthetic growth hormone
Sanofi
1997 Phase 3 NCT00452725 France
MEK162
Array Biopharma, now a wholly owned subsidiary of Pfizer
2012 Phase 2 NCT01556568 United Kingdom;United States
Novartis Pharma Services AG
2012 - EUCTR2011-003392-10-GB United Kingdom;United States
Norditropin
Fujioka Koichi
2022 Phase 3 JPRN-jRCT2031220263 Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russia;Saudi Arabia;Serbia;Slovenia;South Africa;South Korea;Spain;Switzerland
NOVO NORDISK. S.P.A.
2022 Phase 3 EUCTR2021-005607-13-IT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Novo Nordisk A/S
2023 Phase 3 EUCTR2021-005607-13-LT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 NCT05330325 Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 - NCT05308927 France
2022 Phase 3 EUCTR2021-005607-13-FR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Norditropin 24 IU
Novo Nordisk A/S
2005 - EUCTR2005-000042-37-SE Sweden
Norditropin flexpro 10 MG/1.5 ML, solution FOR injection IN PRE-filled PEN
Novo Nordisk A/S
2023 Phase 3 EUCTR2021-005607-13-PT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-SI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-NL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-LV Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-IE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-HR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-FI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-DE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BG Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-PL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-GR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Norditropin simplexx
Novo Nordisk A/S
2005 - EUCTR2005-000042-37-SE Sweden
Oral glucose tolerance test
University Hospital, Toulouse
2015 - NCT02383316 France
Polyethylene glycol
Shallghai Children's Medical Center
2022 Phase 4 ChiCTR2200065823 China
Rhigf-1/rhigfbp-3
Insmed Incorporated
2006 Phase 2 NCT00351221 United States
Simvastatin
University Hospital Toulouse
2016 Phase 3 EUCTR2016-000647-14-FR France
University Hospital, Toulouse
2017 Phase 3 NCT02713945 France
Sogroya 10 MG/1.5 ML solution FOR injection IN PRE-filled PEN
NOVO NORDISK. S.P.A.
2022 Phase 3 EUCTR2021-005607-13-IT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Novo Nordisk A/S
2023 Phase 3 EUCTR2021-005607-13-PT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-SI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-NL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-LV Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-IE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-HR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-FI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-DE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BG Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-PL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-GR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Sogroya 10 MG/1.5 ML soluzione PER iniezione IN penna PRE-riempita
NOVO NORDISK. S.P.A.
2022 Phase 3 EUCTR2021-005607-13-IT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Sogroya 5 MG/1.5 ML solution FOR injection IN PRE-filled PEN
Novo Nordisk A/S
2022 Phase 3 EUCTR2021-005607-13-BE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Somapacitan
Fujioka Koichi
2022 Phase 3 JPRN-jRCT2031220263 Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russia;Saudi Arabia;Serbia;Slovenia;South Africa;South Korea;Spain;Switzerland
Novo Nordisk A/S
2023 Phase 3 NCT05723835 Korea, Republic of;Malaysia;Netherlands;Poland;Spain;United States
2023 Phase 3 EUCTR2021-005607-13-LT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 NCT05330325 Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-FR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Somapacitan 15 MG/1.5 ML PDS290
NOVO NORDISK. S.P.A.
2022 Phase 3 EUCTR2021-005607-13-IT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Novo Nordisk A/S
2023 Phase 3 EUCTR2021-005607-13-PT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-SI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-NL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-LV Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-IE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-HR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-FI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-DE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BG Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-PL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-GR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Somapacitan 5 MG/1.5 ML PDS290
NOVO NORDISK. S.P.A.
2022 Phase 3 EUCTR2021-005607-13-IT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Novo Nordisk A/S
2023 Phase 3 EUCTR2021-005607-13-PT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-SI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-NL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-LV Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-IE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-HR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-FI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-DE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BG Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-PL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-GR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Somatropin
NOVO NORDISK. S.P.A.
2022 Phase 3 EUCTR2021-005607-13-IT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Novo Nordisk A/S
2023 Phase 3 EUCTR2021-005607-13-PT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-SI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-NL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-LV Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-IE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-HR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-FI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-DE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BG Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2018 - NCT03435627 Japan
2013 Phase 3 NCT01927861 Japan
2008 Phase 3 NCT01529944 Sweden
2006 - NCT00960128 Argentina;Belgium;Brazil;Czech Republic;Czechia;Denmark;Finland;Former Serbia and Montenegro;France;Germany;Hungary;Ireland;Israel;Italy;Lithuania;Luxembourg;Netherlands;Norway;Russian Federation;Saudi Arabia;Serbia;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2005 - EUCTR2005-000042-37-SE Sweden
1990 Phase 3 NCT01529840 Sweden
- Phase 3 EUCTR2021-005607-13-PL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-GR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Somatropina
NOVO NORDISK. S.P.A.
2022 Phase 3 EUCTR2021-005607-13-IT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Standard therapy
Medical University of Warsaw
2024 Phase 2 NCT06555237 Poland
Trametinib tablet
Medical University of Warsaw
2024 Phase 2 NCT06555237 Poland
Vosoritide injection
BioMarin Pharmaceutical
2024 Phase 2 NCT06668805 France;Spain;United States
University Hospital, Toulouse
2022 - NCT05202210 France
Blood sample
Assistance Publique - Hôpitaux de Paris
2024 - NCT06147414 France
Growth hormone
Fujioka Koichi
2022 Phase 3 JPRN-jRCT2031220263 Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russia;Saudi Arabia;Serbia;Slovenia;South Africa;South Korea;Spain;Switzerland
Human growth hormone
BioMarin Pharmaceutical
2024 Phase 2 NCT06668805 France;Spain;United States
Shallghai Children's Medical Center
2022 Phase 4 ChiCTR2200065823 China
Lamotrigin beta
Technische Universität München, Fakultät für Medizin
2018 Phase 2 EUCTR2016-005022-10-DE Germany
Lovastatin
Technische Universität München, Fakultät für Medizin
2018 Phase 2 EUCTR2016-005022-10-DE Germany
Maxomat ®, biosynthetic growth hormone
Sanofi
1997 Phase 3 NCT00452725 France
MEK162
Array Biopharma, now a wholly owned subsidiary of Pfizer
2012 Phase 2 NCT01556568 United Kingdom;United States
Novartis Pharma Services AG
2012 - EUCTR2011-003392-10-GB United Kingdom;United States
Norditropin
Fujioka Koichi
2022 Phase 3 JPRN-jRCT2031220263 Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russia;Saudi Arabia;Serbia;Slovenia;South Africa;South Korea;Spain;Switzerland
NOVO NORDISK. S.P.A.
2022 Phase 3 EUCTR2021-005607-13-IT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Novo Nordisk A/S
2023 Phase 3 EUCTR2021-005607-13-LT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 NCT05330325 Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 - NCT05308927 France
2022 Phase 3 EUCTR2021-005607-13-FR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Norditropin 24 IU
Novo Nordisk A/S
2005 - EUCTR2005-000042-37-SE Sweden
Norditropin flexpro 10 MG/1.5 ML, solution FOR injection IN PRE-filled PEN
Novo Nordisk A/S
2023 Phase 3 EUCTR2021-005607-13-PT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-SI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-NL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-LV Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-IE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-HR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-FI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-DE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BG Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-PL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-GR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Norditropin simplexx
Novo Nordisk A/S
2005 - EUCTR2005-000042-37-SE Sweden
Oral glucose tolerance test
University Hospital, Toulouse
2015 - NCT02383316 France
Polyethylene glycol
Shallghai Children's Medical Center
2022 Phase 4 ChiCTR2200065823 China
Rhigf-1/rhigfbp-3
Insmed Incorporated
2006 Phase 2 NCT00351221 United States
Simvastatin
University Hospital Toulouse
2016 Phase 3 EUCTR2016-000647-14-FR France
University Hospital, Toulouse
2017 Phase 3 NCT02713945 France
Sogroya 10 MG/1.5 ML solution FOR injection IN PRE-filled PEN
NOVO NORDISK. S.P.A.
2022 Phase 3 EUCTR2021-005607-13-IT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Novo Nordisk A/S
2023 Phase 3 EUCTR2021-005607-13-PT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-SI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-NL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-LV Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-IE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-HR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-FI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-DE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BG Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-PL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-GR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Sogroya 10 MG/1.5 ML soluzione PER iniezione IN penna PRE-riempita
NOVO NORDISK. S.P.A.
2022 Phase 3 EUCTR2021-005607-13-IT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Sogroya 5 MG/1.5 ML solution FOR injection IN PRE-filled PEN
Novo Nordisk A/S
2022 Phase 3 EUCTR2021-005607-13-BE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Somapacitan
Fujioka Koichi
2022 Phase 3 JPRN-jRCT2031220263 Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russia;Saudi Arabia;Serbia;Slovenia;South Africa;South Korea;Spain;Switzerland
Novo Nordisk A/S
2023 Phase 3 NCT05723835 Korea, Republic of;Malaysia;Netherlands;Poland;Spain;United States
2023 Phase 3 EUCTR2021-005607-13-LT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 NCT05330325 Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-FR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Somapacitan 15 MG/1.5 ML PDS290
NOVO NORDISK. S.P.A.
2022 Phase 3 EUCTR2021-005607-13-IT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Novo Nordisk A/S
2023 Phase 3 EUCTR2021-005607-13-PT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-SI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-NL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-LV Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-IE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-HR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-FI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-DE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BG Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-PL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-GR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Somapacitan 5 MG/1.5 ML PDS290
NOVO NORDISK. S.P.A.
2022 Phase 3 EUCTR2021-005607-13-IT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Novo Nordisk A/S
2023 Phase 3 EUCTR2021-005607-13-PT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-SI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-NL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-LV Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-IE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-HR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-FI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-DE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BG Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-PL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-GR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Somatropin
NOVO NORDISK. S.P.A.
2022 Phase 3 EUCTR2021-005607-13-IT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Novo Nordisk A/S
2023 Phase 3 EUCTR2021-005607-13-PT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-SI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-NL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-LV Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-IE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-HR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-FI Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-DE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BG Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2022 Phase 3 EUCTR2021-005607-13-BE Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
2018 - NCT03435627 Japan
2013 Phase 3 NCT01927861 Japan
2008 Phase 3 NCT01529944 Sweden
2006 - NCT00960128 Argentina;Belgium;Brazil;Czech Republic;Czechia;Denmark;Finland;Former Serbia and Montenegro;France;Germany;Hungary;Ireland;Israel;Italy;Lithuania;Luxembourg;Netherlands;Norway;Russian Federation;Saudi Arabia;Serbia;Slovenia;Spain;Sweden;Switzerland;United Kingdom
2005 - EUCTR2005-000042-37-SE Sweden
1990 Phase 3 NCT01529840 Sweden
- Phase 3 EUCTR2021-005607-13-PL Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
- Phase 3 EUCTR2021-005607-13-GR Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;European Union;Finland;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Somatropina
NOVO NORDISK. S.P.A.
2022 Phase 3 EUCTR2021-005607-13-IT Austria;Belgium;Brazil;Bulgaria;Canada;China;Croatia;Finland;France;Germany;Greece;India;Ireland;Israel;Italy;Japan;Korea, Republic of;Latvia;Lithuania;Malaysia;Mexico;Netherlands;Poland;Portugal;Russian Federation;Saudi Arabia;Serbia;Slovenia;South Africa;Spain;Switzerland;Thailand;United Kingdom;United States
Standard therapy
Medical University of Warsaw
2024 Phase 2 NCT06555237 Poland
Trametinib tablet
Medical University of Warsaw
2024 Phase 2 NCT06555237 Poland
Vosoritide injection
BioMarin Pharmaceutical
2024 Phase 2 NCT06668805 France;Spain;United States